{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:51:18Z","timestamp":1788544278503,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd014803","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000}}],"reference-count":149,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014803.pub2","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T06:53:18Z","timestamp":1732085598000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Omega-3 fatty acid supplementation for depression in children and adolescents"],"prefix":"10.1002","volume":"2024","author":[{"given":"Susan C","family":"Campisi","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; The Hospital for Sick Children; Toronto Canada"},{"name":"Dalla Lana School of Public Health, Clinical Public Health Division, Nutrition and Dietetics Program; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Zasowski","sequence":"additional","affiliation":[{"name":"Cundill Centre for Child and Youth Depression; Centre for Addiction and Mental Health; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyneva","family":"Bradley-Ridout","sequence":"additional","affiliation":[{"name":"Gerstein Science Information Centre; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anett","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; The Hospital for Sick Children; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Szatmari","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; The Hospital for Sick Children; Toronto Canada"},{"name":"Cundill Centre for Child and Youth Depression; Centre for Addiction and Mental Health; Toronto Canada"},{"name":"Division of Child and Youth Mental Health, Department of Psychiatry; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Korczak","sequence":"additional","affiliation":[{"name":"Department of Psychiatry; The Hospital for Sick Children; Toronto Canada"},{"name":"Department of Psychiatry, Faculty of Medicine; University of Toronto; Toronto Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/cap.2016.0123","article-title":"Omega-3 fatty acid plasma levels before and after supplementation: correlations with mood and clinical outcomes in the omega-3 and therapy studies","volume":"27","author":"Arnold","year":"2017","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Fristad MA Black SR Arnold LE Long-term naturalistic follow-up of youth with mood disorders following omega-3 treatment and psychotherapy Journal of the American Academy of Child & Adolescent Psychiatry 2016 55 10 Suppl 1 S335 10.1016\/j.jaac.2016.07.404","DOI":"10.1016\/j.jaac.2016.07.404"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2020.11.115","article-title":"Moody kids years later: long-term outcomes of youth from the omega-3 and therapy (OATS) studies","volume":"281","author":"Fristad","year":"2021","journal-title":"Journal of Affective Disorders"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014803.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1080\/15374416.2016.1233500","article-title":"Pilot randomized controlled trial of omega-3 and individual-family psychoeducational psychotherapy for children and adolescents with depression","volume":"48","author":"Fristad","year":"2019","journal-title":"Journal of Clinical Child and Adolescent Psychology"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1089\/cap.2015.0132","article-title":"A randomized controlled trial of individual family psychoeducational psychotherapy and omega-3 fatty acids in youth with subsyndromal bipolar disorder","volume":"25","author":"Fristad","year":"2015","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014803.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1080\/15374416.2017.1342547","article-title":"Not all masks are created equal: masking success in clinical trials of children and adolescents","volume":"48","author":"Jones","year":"2019","journal-title":"Journal of Clinical Child and Adolescent Psychology"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/jcpp.12830","article-title":"Omega-3 supplementation associated with improved parent-rated executive function in youth with mood disorders: secondary analyses of the omega 3 and therapy (OATS) trials","volume":"59","author":"Vesco","year":"2018","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s10802-016-0203-3","article-title":"Psychoeducational psychotherapy and omega-3 supplementation improve co-occurring behavioral problems in youth with depression: results from a pilot RCT","volume":"45","author":"Young","year":"2017","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014803.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/15374416.2016.1146992","article-title":"Predicting therapeutic effects of psychodiagnostic assessment among children and adolescents participating in randomized controlled trials","volume":"48","author":"Young","year":"2019","journal-title":"Journal of Clinical Child and Adolescent Psychology"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0010|cit10","first-page":"17m11596","article-title":"A double-blind placebo-controlled trial of omega-3 fatty acids as a monotherapy for adolescent depression","volume":"79","author":"Gabbay","year":"2018","journal-title":"Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.jaac.2016.09.213","article-title":"Randomized control trial of omega-3 fatty acids in adolescents with major depressive disorder","volume":"55","author":"Stadterman","year":"2016","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1179\/1476830514Y.0000000135","article-title":"Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study","volume":"19","author":"McNamara","year":"2016","journal-title":"Nutritional Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bdi.13110.","article-title":"#6191 \u2013 McNamara 2021 Fish oil supplementation alters emotion-generated corticolimbic functional connectivity in depressed adolescents at high-risk for bipolar I disorder: a 12-week placebo-controlled fMRI trial","volume":"24","author":"McNamara","year":"2021","journal-title":"Bipolar Disorders"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/cap.2019.0124","article-title":"Effects of fish oil monotherapy on depression and prefrontal neurochemistry in adolescents at high risk for bipolar I disorder: a 12-week placebo-controlled proton magnetic resonance spectroscopy trial","volume":"30","author":"McNamara","year":"2020","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.phanu.2014.02.002","article-title":"Detection and treatment of long-chain omega-3 fatty acid deficiency in adolescents with SSRI-resistant major depressive disorder","volume":"2","author":"McNamara","year":"2014","journal-title":"PharmaNutrition"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","article-title":"Omega-3 treatment of childhood depression: a controlled, double-blind pilot study","volume":"163","author":"Nemets","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD014803.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/antiox10081256","article-title":"Oxidative stress markers and antioxidant enzymes in children and adolescents with depressive disorder and impact of omega-3 fatty acids in randomised clinical trial","volume":"10","author":"Katrencikova","year":"2021","journal-title":"Antioxidants"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/biom10101427","article-title":"Lipid profile, lipoprotein subfractions, and fluidity of membranes in children and adolescents with depressive disorder: effect of omega-3 fatty acids in a double-blind randomized controlled study","volume":"10","author":"Katrencikova","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/nu13041095","article-title":"The effect of omega-3 fatty acids on thromboxane, brain-derived neurotrophic factor, homocysteine, and vitamin D in depressive children and adolescents: randomized controlled trial","volume":"13","author":"Paduchova","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13034-017-0167-2","article-title":"Emulsified omega-3 fatty-acids modulate the symptoms of depressive disorder in children and adolescents: a pilot study","volume":"11","author":"Trebaticka","year":"2017","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"112911","DOI":"10.1016\/j.psychres.2020.112911","article-title":"Omega-3 fatty-acids modulate symptoms of depressive disorder, serum levels of omega-3 fatty acids and omega-6\/omega-3 ratio in children: a randomized, double-blind and controlled trial","volume":"287","author":"Trebaticka","year":"2020","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0022|cit22","first-page":"s49","article-title":"Investigation of omega-6\/omega-3 fatty acids in children with depressive disorder","volume":"56","author":"Trebaticka","year":"2019","journal-title":"European Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014803.pub2-BIB0023|cit23","first-page":"S12","article-title":"Influence of 3-omega fatty acids (FA) on clinical status and inflammatory markers in depressive disorder in children","volume":"63","author":"Trebaticka","year":"2020","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/schbul\/sbx021.042","article-title":"Omega-3 fatty acid versus placebo in a clinical high-risk sample from the North American prodrome longitudinal studies (Napls) consortium","volume":"43","author":"Cadenhead","year":"2017","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0025|cit25","first-page":"19m12742","article-title":"A randomized placebo-controlled trial of omega-3 and sertraline in depressed patients with or at risk for coronary heart disease","volume":"80","author":"Carney","year":"2019","journal-title":"Journal of Clinical Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD014803.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4088\/JCP.14m09267","article-title":"A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study","volume":"76","author":"Chan","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpsychires.2015.12.007","article-title":"Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression","volume":"75","author":"Chhetry","year":"2016","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1601-5215.2007.00189.x","article-title":"Long chain omega-3 polyunsaturated fatty acids in the treatment of psychiatric illnesses in children and adolescents","volume":"19","author":"Clayton","year":"2007","journal-title":"Acta Neuropsychiatrica"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00787-017-1058-z","article-title":"A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms","volume":"27","author":"Cornu","year":"2018","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/ajcn\/86.5.1278","article-title":"Serum phospholipid n 3 long-chain polyunsaturated fatty acids and physical and mental health in a population-based survey of New Zealand adolescents and adults","volume":"86","author":"Crowe","year":"2007","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0031|cit31","unstructured":"Role of omega 3 fatty acid in etiopathogenesis of Depression and trial of two drugs: flax seed oil and Ashwagnadharishta in its management trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/10\/028383"},{"issue":"9","key":"10.1002\/14651858.CD014803.pub2-BIB0032|cit32","first-page":"219","article-title":"Impact of behavioral problems in children under 12 and their families: the EPOCA study","volume":"73","author":"Domenech","year":"2015","journal-title":"Acta Pediatrica Espanola"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S0007114520003888","article-title":"The effect of flaxseed on physical and mental fatigue in children and adolescents with overweight\/obesity: a randomised controlled trial","volume":"126","author":"Gholami","year":"2021","journal-title":"British Journal of Nutrition"},{"issue":"1-2","key":"10.1002\/14651858.CD014803.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.psychres.2015.05.072","article-title":"Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: a preliminary randomized and placebo controlled trial","volume":"229","author":"Ginty","year":"2015","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.106.022707","article-title":"Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial","volume":"190","author":"Hallahan","year":"2007","journal-title":"British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"nu10101478","DOI":"10.3390\/nu10101478","article-title":"Fatty fish intake and the effect on mental health and sleep in preschool children in FINS-KIDS, a randomized controlled trial","volume":"10","author":"Hysing","year":"2018","journal-title":"Nutrients"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1179\/147683009X388887","article-title":"Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10\u201312 years","volume":"12","author":"Kennedy","year":"2009","journal-title":"Nutritional Neuroscience"},{"issue":"8","key":"10.1002\/14651858.CD014803.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbi.2011.07.229","article-title":"Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial","volume":"25","author":"Kiecolt-Glaser","year":"2011","journal-title":"Brain, Behaviour and Immunity"},{"issue":"107","key":"10.1002\/14651858.CD014803.pub2-BIB0039|cit39","first-page":"1","article-title":"The effects of omega-3 fatty acids on depression in female students","volume":"17","author":"Kooshki","year":"2014","journal-title":"Iranian Journal of Obstetrics, Gynecology and Infertility"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0040|cit40","unstructured":"Lesperance F Frasure-Smith N A pilot study of omega-3 supplements for depression 63rd Annual Meeting of the American Psychosomatic Society; 2005 March 2-5; Vancouver (Canada)"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","article-title":"Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial","volume":"74","author":"McGorry","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD014803.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11745-013-3801-7","article-title":"Improvement of major depression is associated with increased erythrocyte DHA","volume":"48","author":"Meyer","year":"2013","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0044|cit44","unstructured":"Omega-3 fatty acids as adjunct treatment for major depressive disorder clinicaltrials.gov\/show\/NCT00511810"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0045|cit45","unstructured":"Effects of fish-oil on mood and cognitive functions of healthy individuals clinicaltrials.gov\/show\/NCT01104194"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0046|cit46","unstructured":"Omega-3 and therapy study for depression clinicaltrials.gov\/show\/NCT01341925"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0047|cit47","unstructured":"Role of omega-3 polyunsaturated fatty acid in the management of major depressive disorder clinicaltrials.gov\/show\/NCT03732378"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-018-0052-x","article-title":"NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders \u2013 medium-term follow-up and clinical course","volume":"4","author":"Nelson","year":"2018","journal-title":"NPJ Schizophrenia"},{"issue":"2-3","key":"10.1002\/14651858.CD014803.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000377640","article-title":"Supplementation of n-3 polyunsaturated fatty acids for major depressive disorder: a randomized, double-blind, 12-week, placebo-controlled trial in Korea","volume":"66","author":"Park","year":"2015","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/jcpp.12314","article-title":"Reduction in behavior problems with omega-3 supplementation in children aged 8\u201316 years: a randomized, double-blind, placebo-controlled, stratified, parallel-group trial","volume":"56","author":"Raine","year":"2015","journal-title":"Journal of Child Psychology and Psychiatry"},{"issue":"S2","key":"10.1002\/14651858.CD014803.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"S273","DOI":"10.1038\/npp.2013.280","article-title":"Inflammation, depression and N-3 fatty acids: a case of personalized medicine","volume":"38","author":"Rapaport","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Molecular Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD014803.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.biopsych.2020.02.126","article-title":"Does n-3 fatty acid supplementation impact immune and clinical outcomes in inflammatory depression?","volume":"87","author":"Rapaport","year":"2020","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2018.09.006","article-title":"A potential role for adjunctive omega-3 polyunsaturated fatty acids for depression and anxiety symptoms in recent onset psychosis: results from a 16 week randomized placebo-controlled trial for participants concurrently treated with risperidone","volume":"204","author":"Robinson","year":"2019","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19390211.2018.1481165","article-title":"Impact of omega-3 fatty acids among other nonpharmacological interventions on behavior and quality of life in children with compromised conduct in Spain","volume":"17","author":"Rodriguez-Hernandez","year":"2020","journal-title":"Journal of Dietary Supplements"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1097\/PSY.0000000000000699","article-title":"Abstracts of the 77th Annual Scientific Meeting, March 6\u20139, 2019. Vancouver, BC, Canada","volume":"81","author":"Salem","year":"2019","journal-title":"Psychosomatic Medicine"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0057|cit57","first-page":"56","article-title":"Essential fatty acids and brain function in children","volume":"148","author":"Schuchardt","year":"2008","journal-title":"Deutsche Apotheker Zeitung"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.plefa.2004.11.004","article-title":"Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression","volume":"72","author":"Silvers","year":"2005","journal-title":"Prostaglandins, Leukotrienes & Essential Fatty Acids"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/1028415X.2017.1283128","article-title":"Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: an open-label pilot trial","volume":"21","author":"Smith","year":"2018","journal-title":"Nutritional Neuroscience"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"7","key":"10.1002\/14651858.CD014803.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.biopsych.2014.01.008","article-title":"Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial","volume":"76","author":"Su","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0062|cit62","first-page":"131","article-title":"Polyunsaturated fatty acids in treatment of mental disorders in children and adolescents: a review","volume":"12","author":"Tyszkiewicz","year":"2009","journal-title":"Wiadomosci Psychiatryczne"},{"issue":"7","key":"10.1002\/14651858.CD014803.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"e011790","DOI":"10.1136\/bmjopen-2016-011790","article-title":"A protocol for a randomised controlled trial investigating the effect of increasing omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents","volume":"6","author":"Wurff","year":"2016","journal-title":"BMJ Open"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0064|cit64","first-page":"nu8010013","article-title":"Association between blood omega-3 index and cognition in typically developing Dutch adolescents","volume":"8","author":"Wurff","year":"2016","journal-title":"Nutrients"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00394-018-1667-4","article-title":"Exploring the association between whole blood Omega-3 Index, DHA, EPA, DHA, AA and n-6 DPA, and depression and self-esteem in adolescents of lower general secondary education","volume":"58","author":"Wurff","year":"2019","journal-title":"European Journal of Nutrition"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"102208","DOI":"10.1016\/j.plefa.2020.102208","article-title":"Effect of one year krill oil supplementation on depressive symptoms and self-esteem of Dutch adolescents: a randomized controlled trial","volume":"163","author":"Wurff","year":"2020","journal-title":"Prostaglandins, Leukotrienes & Essential Fatty Acids"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"S341","DOI":"10.1016\/j.jaac.2017.07.723","article-title":"Subclinical mood symptoms: working toward a better understanding of phenomenology and treatment","volume":"56","author":"Meter","year":"2017","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0068|cit68","first-page":"1744","article-title":"Consumption of omega-3 fatty acids and depressive symptoms in college students from Sonora, Mexico","volume":"32","author":"Vargas","year":"2015","journal-title":"Nutrici\u00f3n Hospitalaria"},{"issue":"11","key":"10.1002\/14651858.CD014803.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4088\/JCP.14m09267","article-title":"A randomized clinical trial of high eicosapentaenoic acid omega-3 fatty acids and inositol as monotherapy and in combination in the treatment of pediatric bipolar spectrum disorders: a pilot study","volume":"76","author":"Wozniak","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2022.876152","article-title":"Omega-3 polyunsaturated fatty acids supplementation alleviate anxiety rather than depressive symptoms among first-diagnosed, drug-naive major depressive disorder patients: a randomized clinical trial","volume":"9","author":"Yang","year":"2022","journal-title":"Frontiers in Nutrition"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014803.pub2-BIB0071|cit71","first-page":"S1","article-title":"Predicting therapeutic effects of psychodiagnostic assessment among children and adolescents participating in randomized controlled trials","volume":"48","author":"Young","year":"2019","journal-title":"Journal of Clinical Child and Adolescent Psychology"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0072|cit72","unstructured":"Study on the effect of omega-3 polyunsaturated fatty acids in adolescents with depression trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2100041918"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3389\/fpsyt.2019.00863","article-title":"Omega-3 fatty acids as a treatment for pediatric depression. A phase III, 36 weeks, multi-center, double-blind, placebo-controlled randomized superiority study","volume":"10","author":"Haberling","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0074|cit74","unstructured":"The Omega-3 Fatty Acid Paediatric Depression Trial (Omega-3-pMDD) clinicaltrials.gov\/study\/NCT03167307"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0075|cit75","unstructured":"Effects of \u03c9-3 polyunsaturated fatty acid supplementation on depressive symptoms, cognition conditions and plasma metabolome in adolescent patients with depressive disorder trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN68038781 https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN68038781"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0076|cit76","unstructured":"Youth Depression Alleviation: a randomised controlled trial of omega-3 fatty acids (fish oil) for major depressive disorder in young people (YoDA-F) trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12613001352796"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/eip.12166","article-title":"Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): a randomized, double-blind, placebo-controlled treatment trial","volume":"10","author":"Rice","year":"2016","journal-title":"Early Interventional Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0889-1591(02)00009-0","article-title":"Cytokines, stress, and depressive illness","volume":"16","author":"Anisman","year":"2002","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596.dsm05","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0080|cit80","unstructured":"American Psychological Association Guideline Development Panel for the Treatment of Depressive Disorders Clinical practice guideline for the treatment of depression across three age cohorts https:\/\/www.apa.org\/depression-guideline\/guideline.pdf"},{"issue":"11","key":"10.1002\/14651858.CD014803.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004692.pub4","article-title":"Omega-3 fatty acids for depression in adults","author":"Appleton","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00787-013-0411-0","article-title":"Subthreshold depression in adolescence: a systematic review","volume":"10","author":"Bertha","year":"2013","journal-title":"European Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1046\/j.1471-4159.2002.01156.x.","article-title":"Dietary low linolenic acid compared with docosahexaenoic acid alter synaptic plasma membrane phospholipid fatty acid composition and sodium-potassium ATPase kinetics in developing rats","volume":"83","author":"Bowen","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1002\/14651858.CD014803.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/jama.299.8.901","article-title":"Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial","volume":"299","author":"Brent","year":"2008","journal-title":"Journal of the American Medical Association"},{"issue":"7","key":"10.1002\/14651858.CD014803.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3945\/ajcn.112.041343","article-title":"Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish","volume":"96","author":"Browning","year":"2012","journal-title":"American Journal of Clinical Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.plefa.2006.05.013","article-title":"Metabolism of alpha-linolenic acid in humans","volume":"75","author":"Burdge","year":"2006","journal-title":"Prostaglandins, Leukotrienes & Essential Fatty Acids"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.3233\/JIN-170072","article-title":"Fish oil and depression: the skinny on fats","volume":"16","author":"Burhani","year":"2017","journal-title":"Journal of Integrative Neuroscience"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0088|cit88","unstructured":"Canadian Agency for Drugs and Technologies in Health Grey Matters: a practical tool for searching health-related grey literature http:\/\/www.cadth.ca\/resources\/finding-evidence\/grey-matters"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1192\/bjo.2021.1020","article-title":"Eating, sleeping and moving recommendations in clinical practice guidelines for paediatric depression: umbrella review","volume":"7","author":"Campisi","year":"2021","journal-title":"BJPsych Open"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0090|cit90","unstructured":"Campisi S Schumacher A Zasowski C Bradley-Ridout G Szatmari P Korczak DJ ROB2 assessments for omega-3 fatty acid supplementation for depression in children and adolescents, a Cochrane Systematic Review https:\/\/figshare.com\/s\/364b54a1a588158a782e https:\/\/figshare.com\/s\/364b54a1a588158a782e"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0091|cit91","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jad.2020.09.025","article-title":"Depression and inflammation among children and adolescents: a meta-analysis","volume":"277","author":"Colasanto","year":"2020","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0092|cit92","unstructured":"Covidence Veritas Health Innovation"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/10408398.2013.876959","article-title":"Omega 3 polyunsaturated fatty acids and the treatment of depression","volume":"57","author":"Deacon","year":"2017","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0094|cit94","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"7611","key":"10.1002\/14651858.CD014803.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmj.39224.494340.55","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial","volume":"335","author":"Goodyer","year":"2007","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0096|cit96","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime)"},{"issue":"20","key":"10.1002\/14651858.CD014803.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.3390\/ijms20205028","article-title":"Effects of omega-3 fatty acids on immune cells","volume":"20","author":"Guti\u00e9rrez","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000502652","article-title":"International Society for Nutritional Psychiatry Research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder","volume":"88","author":"Mischoulon","year":"2019","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1192\/bjp.bp.114.160242","article-title":"Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression","volume":"209","author":"Hallahan","year":"2016","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0100|cit100","volume-title":"Encyclopedia of Dietary Supplements","author":"Harris","year":"2010"},{"issue":"6984","key":"10.1002\/14651858.CD014803.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.310.6984.897","article-title":"Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis","volume":"310","author":"Hazell","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0102|cit102","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0103|cit103","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fphar.2019.01022","article-title":"N-3 polyunsaturated fatty acids and the resolution of neuroinflammation","volume":"13","author":"Joffre","year":"2019","journal-title":"Frontiers in Pharmacology"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0105|cit105","unstructured":"Adult and adolescent depression screening, diagnosis, and treatment guideline https:\/\/wa.kaiserpermanente.org\/static\/pdf\/public\/guidelines\/depression.pdf"},{"issue":"9","key":"10.1002\/14651858.CD014803.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.3390\/ijms22094393","article-title":"Disentangling the molecular mechanisms of the antidepressant activity of omega-3 polyunsaturated fatty acid: a comprehensive review of the literature","volume":"22","author":"Kalkman","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1002\/14651858.CD014803.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2174\/1871527311312040004","article-title":"Omega-3 fatty acids and hippocampal neurogenesis in depression","volume":"12","author":"Kang","year":"2013","journal-title":"CNS & Neurological Disorders \u2013 Drug Targets"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"42","DOI":"10.4103\/ijpvm.IJPVM_400_18","article-title":"Nutritional aspects of depression in adolescents \u2013 a systematic review","volume":"10","author":"Khanna","year":"2019","journal-title":"International Journal of Preventive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpeds.2009.01.061","article-title":"Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample","volume":"155","author":"Korczak","year":"2009","journal-title":"Journal of Pediatrics"},{"issue":"15","key":"10.1002\/14651858.CD014803.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.3390\/ijms21155220","article-title":"The association of free fatty acids and eicosanoids with the severity of depressive symptoms in stroke patients","volume":"21","author":"Kotlega","year":"2020","journal-title":"International Journal of Molecular Science"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0111|cit111","volume-title":"The Encyclopedia of Clinical Psychology","year":"2015"},{"issue":"86","key":"10.1002\/14651858.CD014803.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbi.2019.04.028","article-title":"Early life adversity exposure and circulating markers of inflammation in children and adolescents: a systematic review and meta-analysis","volume":"1","author":"Kuhlman","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0113|cit113","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Translational Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD014803.pub2-BIB0115|cit115","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0116|cit116","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"10","key":"10.1002\/14651858.CD014803.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1476-511X-3-25","article-title":"Omega-3 fatty acids and major depression: a primer for the mental health professional","volume":"3","author":"Logan","year":"2004","journal-title":"Lipids in Health and Disease"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jad.2015.04.014","article-title":"A review of nutrient treatments for paediatric depression","volume":"181","author":"Lopresti","year":"2015","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12888-020-02656-3","article-title":"High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis","volume":"20","author":"Luo","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0122|cit122","first-page":"35","article-title":"Depression in childhood and adolescence","volume":"22","author":"Maughan","year":"2013","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"\u200bMcGowan","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/HRP.0000000000000199","article-title":"Omega-3 polyunsaturated fatty acid deficiency and progressive neuropathology in psychiatric disorders: a review of translational evidence and candidate mechanisms","volume":"27","author":"McNamara","year":"2019","journal-title":"Harvard Review of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Translational Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD014803.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.bbalip.2014.12.014","article-title":"Brain membrane lipids in major depression and anxiety disorders","volume":"1851","author":"Muller","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0127|cit127","unstructured":"National Institutes of Health (NIH): National Center for Complementary and Integrative Health (NCCIH) Omega-3 supplements: in depth http:\/\/www.nccih.nih.gov\/health\/omega3-supplements-in-depth"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/archpsyc.58.9.844","article-title":"Excess mortality in bipolar and unipolar disorder in Sweden","volume":"58","author":"Osby","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD014803.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychological Medicine"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1176\/ajp.2006.163.6.969","article-title":"Omega-3 fatty acids and mood disorders","volume":"163","author":"Parker","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/1073191116669784","article-title":"How small is big: sample size and skewness","volume":"25","author":"Piovesana","year":"2018","journal-title":"Assessment"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0132|cit132","volume-title":"Children's Depression Rating Scale, Revised (CDRS-R)","author":"Poznanski","year":"1996"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0133|cit133","unstructured":"R: A language and environment for statistical computing R Foundation for Statistical Computing 2024"},{"issue":"11","key":"10.1002\/14651858.CD014803.pub2-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","article-title":"Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis","volume":"175","author":"Racine","year":"2021","journal-title":"JAMA Pediatrics"},{"issue":"9","key":"10.1002\/14651858.CD014803.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0706743716660290","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments","volume":"61","author":"Ravindran","year":"2016","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0136|cit136","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"3","key":"10.1002\/14651858.CD014803.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1542\/peds.2007-1529","article-title":"Improving pediatric dosing through pediatric initiatives: what we have learned","volume":"121","author":"Rodriguez","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0138|cit138","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Guyatt GH Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook\/archive\/v6.3"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"67","DOI":"10.9758\/cpn.2018.16.1.67","article-title":"Korean Medication Algorithm for Depressive Disorders 2017: Third Revision","volume":"16","author":"Seo","year":"2018","journal-title":"Clinical Psychopharmacology Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD014803.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/M15-2957","article-title":"Screening for depression in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD014803.pub2-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ypmed.2005.11.005","article-title":"\u03c9-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique","volume":"42","author":"Sontrop","year":"2006","journal-title":"Preventive Medicine"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0142|cit142","volume-title":"Critical Issues in Psychiatric Diagnosis","author":"Spitzer","year":"1978"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0143|cit143","volume-title":"Biometrics Research Unit","author":"Spitzer","year":"1995"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD014803.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1037\/a0040360","article-title":"What five decades of research tells us about the effects of youth psychological therapy: a multilevel meta-analysis and implications for science and practice","volume":"72","author":"Weisz","year":"2017","journal-title":"American Psychologist"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0146|cit146","volume-title":"International Statistical Classification of Diseases and Related Health Problems (ICD-10)","author":"World Health Organization","year":"2016"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13034-019-0296-x","article-title":"Omega-3 fatty acids for the treatment of depressive disorders in children and adolescents: a meta-analysis of randomized placebo-controlled trials","volume":"13","author":"Zhang","year":"2019","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"key":"10.1002\/14651858.CD014803.pub2-BIB0148|cit148","unstructured":"World Health Organization Depression fact sheet https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression"},{"issue":"6","key":"10.1002\/14651858.CD014803.pub2-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014803","article-title":"Omega-3 fatty acid supplementation for depression in children and adolescents","author":"Campisi","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:33:46Z","timestamp":1786595626000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014803.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":149,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014803.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]}}}